Clinical Trial Update: Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)

View source ↗

Summary

This clinical trial update provides extended overall survival data from the PARSIFAL study (PARSIFAL-LONG) in metastatic/advanced breast cancer, highlighting lo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer
• Luminal Breast Cancer

Snippet

Sponsor: MedSIR | Conditions: Metastatic Breast Cancer, Advanced Breast Cancer | Status: COMPLETED